Mitochondrial respiratory chain as a new target for anti-ischemic molecules

European Journal of Pharmacology

Volumn 441, Issue 1-2, 2002, Pages 35-45

  Bouaziz, Najat ^a   Redon, Martine ^a   Quéré, Luc ^a   Remacle, José ^a   Michiels, Carine ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Anti ischemic molecule; Complex I; Endothelial cell; Hypoxia; Mitochondrion; Respiration

Indexed keywords

1,5 DIOXOSPIRO 2,6 NONANEDIONE; 2,6 DIMETHYLHEXAHYDROFUROFURAN 4,8 DIONE; AMOBARBITAL; BILOBALIDE; BN 50504; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; MRC 2 P 119; MRC 2 P 141; MRC 2 P 45; MRC 2 P 55; MRC 2 P 57; MRC 3 P 133; MRC 3 P 47; MYXOTHIAZOL; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL ACTIVATION; CELL ADHESION; CELL CULTURE; CELL TYPE; CELL VIABILITY; CHRONIC VEIN INSUFFICIENCY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFECT; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SYNTHESIS; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; HYPOXIA; MITOCHONDRIAL RESPIRATION; NEUROBLASTOMA CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; THROMBOSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; BICYCLO COMPOUNDS; CARDIOVASCULAR AGENTS; CELL ADHESION; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; CYCLOPENTANES; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRON TRANSPORT; ESTERS; FEMALE; FURANS; GINKGOLIDES; HUMANS; ISCHEMIA; MALONATES; MITOCHONDRIA, LIVER; NEUTROPHILS; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0037134281     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01490-5     Document Type: Article

References (47)

1. Changes of respiratory chain activity in mitochondrial and synaptosomal fractions isolated from the gerbil brain after graded ischaemia
2. Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/CD11b and ICAM-1
3. Hypoxic human umbilical vein endothelial cells induce activation of adherent polymorphonuclear leukocytes
4. Effect of aescine on hypoxia-induced activation of human endothelial cells
5. Effect of Ginkor Fort on hypoxia-induced neutrophil adherence to human spahenous vein endothelium
6. Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication
7. Decline in age of the respiratory chain activity in human skeletal muscle
8. Control and kinetic analysis of ischemia-damaged heart mitochondria: Which parts of the oxidative phosphorylation system are affected by ischemia
9. Pathophysiology of ischaemiareperfusion injury
10. Treatment of chronic myocardial ischemia: Rationale and treatment options
11. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury
12. Mitochondrial function as a determinant of recovery or death in cell response to injury
13. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion
14. Superoxide activates mitochondrial uncoupling proteins
15. Ischaemic heart disease: Clinical improvement with metabolic approach
16. Mitochondrial participation in ischemic and traumatic neural cell death
17. Control of mitochondrial substrate oxidation
18. Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficency in old age
19. Culture of human endothelial cells derived from umbilical veins
20. Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide
21. Effects of hydroxyethylrutosides on hypoxia-induced activation of human endothelial cells in vitro
22. Protection of mitochondrial respiration activity by bilobalide
23. Effect of venotropic drugs on the respiratory activity of isolated mitochondria and in endothelial cells
24. Protection by bilobalide of the ischemia-induced alterations of the mitochondrial respiratory activity
25. Early phase of myocaridal ischemic injury and function
26. Uncoupling proteins: The issues from a biochemist point of view
27. Neuroprotective effects of Ginkgo biloba constituents
28. Metabolite transport in mitochondria
29. Effects of Ginkgo biloba extract on changes induced by quantitative cerebral microembolization in rats
30. Human umbilical vein endothelial cell submitted to hypoxia-reoxygenation in vitro: Implication of free radicals, xanthine oxydase and energy deficiency
31. Effects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells
32. Endothelial cell responses to hypoxia: Initiation of a cascade of cellular interactions
33. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPO2 determination
34. Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema
35. Cardioprotective and anti-oxidant effect of the terpenoid constituents of Ginkgo biloba extract (EGb 761)
36. The anti-ischemic potential of angiotensin-converting enzyme inhibition: Insights from the heart outcomes prevention evaluation trial
37. Ca2+ release from mitochondria induced by prooxidants
38. Selection of drug therapy in stable angina pectoris
39. Mitochondrial free calcium regulation in hypoxia and reoxygenation: Relation to cellular injury
40. Effect of Ginkgo biloba extract (EGb761) on oxygen consumption by isolated cerebral mitochondria
41. Mitochondria proton leak and the uncoupling protein 1 homologues
42. Ischemia-induced damages in cerebral mitochondrial free fatty acids, phospholipids, and respiration in the rat
43. Energy metabolism in reperfused heart muscle: Metabolic correlates to return of function
44. End organ protection by calcium-channel blockers
45. Global ischaemia induces a biphasic response of the mitochondrial respiratory chain (anoxic pre-prefusion protects again ischaemic damage)
46. Ginkgo biloba leaf extract: Review of biological actions and clinical applications